SG, T., IL, M., B, B., L, H., S, B., S, R., . . . D, V. (2020). CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. PLoS neglected tropical diseases, 14(2), e0008050. https://doi.org/10.1371/journal.pntd.0008050
Chicago Style (17th ed.) CitationSG, Thacker, et al. "CpG ODN D35 Improves the Response to Abbreviated Low-dose Pentavalent Antimonial Treatment in Non-human Primate Model of Cutaneous Leishmaniasis." PLoS Neglected Tropical Diseases 14, no. 2 (2020): e0008050. https://doi.org/10.1371/journal.pntd.0008050.
MLA (9th ed.) CitationSG, Thacker, et al. "CpG ODN D35 Improves the Response to Abbreviated Low-dose Pentavalent Antimonial Treatment in Non-human Primate Model of Cutaneous Leishmaniasis." PLoS Neglected Tropical Diseases, vol. 14, no. 2, 2020, p. e0008050, https://doi.org/10.1371/journal.pntd.0008050.